Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMX1/TMX4 correlation study in delayed encephalopathy after carbon monoxide poisoning
ChiCTR2400091657Phase 4Recruiting
- Sponsor
- Shanxi Bethune Hospital
- Start
- Oct 2024
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of glutathione in Carboxyhemoglobinemia (COHb) and Delayed neurological sequelae (DNS) (5 arms), sponsored by Shanxi Bethune Hospital. Primary endpoints: Blood gas analysis, TMX1/TMX4 and 5 more. Started Oct 2024; status: recruiting.
02
Drugs
glutathione
03
Conditions
Carboxyhemoglobinemia (COHb)Delayed neurological sequelae (DNS)
Beyond the preview
Go deeper on ChiCTR2400091657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091657.